Screening process for atopic dermatitis
AssigneeThe Scripps Research Institute
InventorsEng M Tan, Robert L Ochs, Edward K L Chan, Yoshinao Muro
Life of this patent
Estimating the term…
Abstract
The present invention provides a process of screening patients for atopic dermatitis. The process includes the step of determining, in sera of the patient, the presence of antibodies against nuclear antigens such as transcription co-activator p75, wherein the presence of such antibodies indicates atopic dermatitis. The screening process can be used to detect atopic dermatitis in patients suffering from other conditions such as asthma or interstitial cystitis.
Claims6
A process of screening a patient for atopic dermatitis comprising determining in sera of the patient the presence of antibodies against nuclear transcription co-activator p75, wherein the presence of such antibodies indicates atopic dermatitis.
Dependencies are inferred from the claim text.